These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21361855)

  • 21. A novel specific bioassay for serum human growth hormone.
    Ishikawa M; Nimura A; Horikawa R; Katsumata N; Arisaka O; Wada M; Honjo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4274-9. PubMed ID: 11095467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors.
    Okano M; Nishitani Y; Sato M; Kageyama S
    Drug Test Anal; 2012 Sep; 4(9):692-700. PubMed ID: 22733714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum growth hormone measurements in clinical practice: An audit of performance from the UK National External Quality Assessment scheme.
    Seth J; Ellis A; Al-Sadie R
    Horm Res; 1999; 51 Suppl 1():13-9. PubMed ID: 10393486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of recombinant growth hormone in human plasma by a 2-D PAGE method.
    Kohler M; Püschel K; Sakharov D; Tonevitskiy A; Schänzer W; Thevis M
    Electrophoresis; 2008 Nov; 29(22):4495-502. PubMed ID: 19003817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuing efforts to standardize measured serum growth hormone values in Japan.
    Katsumata N; Shimatsu A; Tachibana K; Hizuka N; Horikawa R; Yokoya S; Tatsumi KI; Mochizuki T; Anzo M; Tanaka T
    Endocr J; 2016 Oct; 63(10):933-936. PubMed ID: 27452373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences.
    Bidlingmaier M; Freda PU
    Growth Horm IGF Res; 2010 Feb; 20(1):19-25. PubMed ID: 19818659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic.
    Markkanen HM; Pekkarinen T; Välimäki MJ; Alfthan H; Hämäläinen E; Stenman UH
    Growth Horm IGF Res; 2013 Oct; 23(5):165-9. PubMed ID: 23835226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry.
    Wagner IV; Paetzold C; Gausche R; Vogel M; Koerner A; Thiery J; Arsene CG; Henrion A; Guettler B; Keller E; Kiess W; Pfaeffle R; Kratzsch J
    Eur J Endocrinol; 2014 Sep; 171(3):389-97. PubMed ID: 24966174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone.
    Wu Z; Devany E; Balarini G; Junnila R; Bidlingmaier M; Strasburger CJ
    Growth Horm IGF Res; 2010 Jun; 20(3):239-44. PubMed ID: 20304691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.
    Schriock EA; Lustig RH; Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1043-9. PubMed ID: 6427257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detecting growth hormone abuse in athletes.
    Bidlingmaier M; Manolopoulou J
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):25-32, vii. PubMed ID: 20122447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
    Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
    J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating non-22 kDa growth hormone isoforms after a repeated GHRH stimulus in normal subjects.
    Coya R; Algorta J; Boguszewski CL; Vela A; Carlsson LM; Aniel-Quiroga A; Busturia MA; Martul P
    Growth Horm IGF Res; 2005 Apr; 15(2):123-9. PubMed ID: 15809015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing.
    Hauffa BP; Lehmann N; Bettendorf M; Mehls O; Dörr HG; Stahnke N; Steinkamp H; Said E; Ranke MB;
    Eur J Endocrinol; 2007 Nov; 157(5):597-603. PubMed ID: 17984239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone heterogeneity in human pituitary and plasma.
    Baumann G
    Horm Res; 1999; 51 Suppl 1():2-6. PubMed ID: 10393484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is BaF3 bioassay useful to identify patients with bioinactive growth hormone?
    Pagani S; Chaler EA; Meazza C; Maceiras M; Gonzalez ME; Rivarola MA; Cantoni F; Travaglino P; Della Croce L; Laarej K; Bozzola M; Belgorosky A
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):783-8. PubMed ID: 21073121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.